Darren L. Mungcal BSN 123 Group 92 Evidence Based Nursing
Darren L. Mungcal BSN 123 Group 92 Evidence Based Nursing
Darren L. Mungcal BSN 123 Group 92 Evidence Based Nursing
Mungcal
BSN 123 Group 92
I. Clinical question
Is Multifaceted implementation of stroke prevention guidelines in
primary care clinically and cost effective?
II. Citation
Multifaceted implementation of stroke prevention guidelines in primary
care: cluster-randomised evaluation of clinical and cost effectiveness
A. Patients
Seventy six primary care teams in four clusters: North, South & West,
City I and City II.
B. Interventions Compared
Guidelines for the management of patients with atrial fibrillation
and transient ischaemic attack (TIA) were developed and implemented
using a multifaceted approach including evidence-based
recommendations, audit and feedback, interactive educational
sessions, patient prompts and outreach visits.
C. Outcomes monitored
Identification and appropriate treatment of patients with atrial
fibrillation or TIA, and cost effectiveness. The primary outcomes for TIA
were: the age-sex standardized referral rates to the rapid access TIA
clinic; and guideline compliance measured by proportion of patients
‘‘treated’’ with an anti-platelet drug (already prescribed, prescribed
after the ischaemic event or contra-indicated) and provided with
driving advice by the time they attended the TIA clinic; the data on
driving advice were available only after intervention. The primary
outcomes for atrial fibrillation were: the age-sex standardised
diagnosis rate for patients with atrial fibrillation; and guideline
compliance measured by proportion of patients treated with aspirin or
warfarin or recorded as having a contraindication. Audit of practice
records 21 months after the training workshop used Read codes and
repeat prescription registers to record how many patients in each
practice had been diagnosed with atrial fibrillation, when atrial
fibrillation was first diagnosed, when warfarin or aspirin was prescribed
or contra-indication recorded, and the presence of other risk factors.
IV. Methodology/Design
A. Methodology used: how are the data being obtained?
Step 1: Education meetings
We held a ‘‘protected learning time’’ event in each PCT for
doctors, nurses and practice managers working in secondary care and
across the interface of primary and secondary care. An interactive
approach was taken with small group discussions, problem-based
learning, case histories and worked examples. Local opinion leaders
were identified by each PCT and were given specific training about
leading the meetings.
The aims of the education strategy were to:
• provide events that were accessible and accredited, and met the
needs of the audience.
Step 2: Educational outreach visits
Following the education meetings, each practice was contacted
by the relevant clinical governance lead and offered an outreach visit.
Thirty practices accepted the offer: nine ‘‘Wednesday practices’’ in City
(City I) PCT; eight ‘‘Thursday practices’’ in City (City II) PCT; three
practices in North Bradford PCT; and 10 in South & West PCT. These
were visited by the project leader who presented key messages from
the relevant guideline and discussed the practice’s implementation
strategy during a one-hour session. An information pack containing a
range of materials to support implementation was given out at each
visit, including copies of the guideline, information leaflets, and
electronic and paper copies of referral forms.
Step 3: Postal dissemination
A copy of the information pack was posted to any practice that
did not request a visit.
Reinforcing interventions
The third phase of interventions was designed to reinforce
development and dissemination:
• For South & West PCT we were able to link the audit results to
quality targets in contract agreements.
B. Design
Cluster-randomised trial
C. Setting:
Three primary care organisations in the North of England
covering a population of 400 000.
D. Data sources:
Primary
E. Subject selection:
Three primary care organisations in the North of England
covering a population of 400 000.
Economic evaluation
There is good economic evidence on the cost effectiveness of a variety of
interventions designed to reduce the probability of health-related adverse
outcomes associated with stroke. In particular, for both TIA20 and atrial
fibrillation,21–23 prescription of aspirin produces QALY gains relative to no
therapy, with a net saving in treatment costs.
VII. Applicability
a. Safety
The study shows that it may cause harm (risk for CVA) to the
patient involve on this study. And safety is not guaranteed.
b. Competence of the care provider
The care provider involve upon this study have the guts to
pursue on different test because they have enough skills and
knowledge to view on this kind of research.
c. Acceptability
The study is easily accepted by the people who are greatly
involving on this study.
d. Effectiveness
The research pin points the effectiveness of the study that has
been made.
e. Appropriateness
The interventions made are appropriate enough to stress out the
importance of the study.
f. Efficiency
All of the factors that contribute to this study are efficient to
pursue to its best outcome.
References:
John Wright, John Bibby, Joe Eastham, Stephen Harrison, Maureen McGeorge,
Chris Patterson, Nick Price, Daphne Russell, Ian Russell, Neil Small, Matt
Walsh, John Young